VKTX icon

Viking Therapeutics

140 hedge funds and large institutions have $230M invested in Viking Therapeutics in 2020 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 49 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

less ownership

Funds ownership:

21% less capital invested

Capital invested by funds: $290M → $230M (-$60M)

31% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 49

Holders
140
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$8.28M
Puts
$2.76M
Net Calls
Net Calls Change

Top Buyers

1 +$4.55M
2 +$2.03M
3 +$1.47M
4
SG Americas Securities
SG Americas Securities
New York
+$1.36M
5
Morgan Stanley
Morgan Stanley
New York
+$1.01M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$145K
77
$136K
78
$135K
79
$128K
80
$126K
81
$125K
82
$119K
83
$116K
84
$115K
85
$114K
86
$111K
87
$104K
88
$99K
89
$92K
90
$89.3K
91
$86K
92
$84K
93
$83K
94
$83K
95
$80K
96
$74K
97
$73K
98
$71K
99
$70K
100
$66K